Research Article | Open Access
Long-Term Leukocyte Filtration Should Be Avoided during Extracorporeal Circulation
Filtration during extracorporeal circulation (ECC) not only removes but also activates leukocytes; therefore, long-term leukocyte filtration may cause adverse effects. In the present study, we tested this hypothesis by priming ECC with 300 mL of canine blood and examining filtration effects in 3 groups ( each) during 60 min ECC. In the control group (Group C) blood was filtrated with an arterial filter for 60 min; in long-term (Group L) and short-term (Group S) groups, blood was filtrated with a leukocyte filter for 60 and 5 min. We found that about 90% of leukocytes were removed after 5 min of filtration in both Groups L and S. Although leukocyte count continued to reduce, mean fluorescent intensities of CD11/CD18, free hemoglobin, and neutrophil elastase increased in Group L and were higher than those in Groups C and S at 60 min. Leukocyte rupture, cytoplasmic leakage, and circulating naked nuclei were also found in Group L. The data support our hypothesis that long-term filtration can induce inflammation and lead to leukocyte destruction.
Inflammatory response induced by leukocyte activation during extracorporeal circulation (ECC) is one of the major causes of organ dysfunction [1–3]. Blocking leukocyte activation may attenuate acute lung and renal injuries [4, 5]. Therefore, removing leukocytes by filtration may be beneficial to patients. However, clinical results have been controversial [6–14]. Some studies have suggested that leukocyte filters could reduce expression of CD11b/CD18 in leukocytes , alleviate systemic inflammatory responses [7, 8], and improve outcomes [7, 9, 10]. However, other studies have shown that leukocyte filters cannot reduce , and may even increase, the release of inflammatory cytokines and proteases, and thus could have a negative effect [12–14].
Leukocyte filtration activates leukocytes [14–17], which may enhance inflammatory response during ECC. Our previous in vivo study showed that short-term filtration effectively reduced leukocyte count, and preserved lung function better than long-term filtration. For example, neutrophil elastase (NE) and IL-8 increased during long-term filtration . The results suggest that long-term application of leukocyte filtration may be contraindicated. In the present study, we tested this hypothesis with an ECC model in vitro.
2. Materials and Methods
The study was approved by the Animal Hospital Ethics Committee and all animals in the study received standard care in compliance with the “Guide for the Care and Use of Laboratory Animals.” Eighteen healthy adult hybrid dogs were provided by the Animal Experiment Center of Sichuan University for the study. Dogs (either sex, 23–35 kg BW) were anesthetized with sodium pentobarbital (25 mg/kg). After heparinization (3 mg/kg), 300 mL of blood was harvested from the left femoral artery to a blood bag. Meanwhile, 6% hydroxyethyl starch 130/0.4 (Fresenius Kabi, Germany) was infused from the femoral vein to maintain blood pressure.
2.1. ECC Protocol
A closed ECC loop was established with a blood storage device (Xi-Jing Medical Ltd, Xi’an, China) and a regular arterial filter (Xi-Jing Medical Ltd, Xi’an, China) or a leukocyte filter (Heart-Care System, Separator Haemo-Technology Beijing Co Ltd. China), a roller pump (StÖckert II, Munich, Germany), and tubing. The ECC loop was primed with 300 mL of preserved blood harvested above and 300 mL hydroxyethyl starch 130/0.4. The circulating flow rate was set at 1 L/min, and ECC lasted for 60 min in all groups.
Our pilot study showed that the leukocyte count decreased sharply with low levels of NE after 5 min. Therefore, 5 min was used for “short-term” test in this study. In clinical trials, however, a leukocyte filter is used throughout ECC, often longer than 60 min. Therefore, 60 min was used for “long-term” test.
Established ECCs were divided randomly into 3 groups ( in each group). Blood from the control group (Group C) was filtrated throughout ECC with a standard arterial filter. Blood from Groups L (long-term) and S (short-term) was filtrated with a leukocyte filter for 60 and 5 min (the filter was bypassed in the remaining 55 min). Blood samples were obtained at 0, 5, 30, and 60 min of ECC for indexes analyses.
2.2. Analysis of Blood Cell, NE, and fHb
Cell count and differentiation were performed by an automatic blood cell analyzer (MINDRAY, BC-3000, China) . For measurements of NE and free hemoglobin (fHb) levels, blood samples were centrifuged for 15 minutes at 1000 ×g and 4°C. The supernatant was then removed and stored at −80°C until it was analyzed. NE levels were determined by Enzyme Linked Immunoadsorbent Assay (NE ELISA kits, Uscn Life Science Inc. Wuhan, China), according to the manufacturer’s instruction. The levels of fHb were determined by the orthotolidine method .
2.3. CD11/CD18 Expression
For determination of expression of CD11/CD18 on leukocyte, red blood cells were lysed with ammonium chloride solution, and acquired leukocytes were resuspended in 100 μL of phosphate-buffered saline. Nonspecific antibody binding was blocked with FcR-blocking reagent (Miltenyi Biotec) for 20 min before staining with conjugated antibodies. Immunofluorescent cell staining was performed with Rat anti dog CD11/CD18:FITC (Clone: YKIX490.6.4, AbD Serotec Co., Ltd., Oxford Kidlington, UK). Isotype: IgG2c (AbD Serotec Co., Ltd., Oxford Kidlington, UK) served as a negative control. Data acquisition was performed on a FACSAria cytometer equipped with FACS Diva 5.0 software (BD) and analyzed by Flowjo software (Tree Star) [4, 21].
2.4. Morphology of Circulating Nucleated Cells
Circulating integral leukocytes were determined as we described previously . Briefly, red blood cells were lysed; the sample was centrifuged at 302 ×g for 5 min and washed with PBS 3 times. Nucleated cell suspensions were smeared and stained with Wright’s stain. One hundred nucleated cells per slide were counted under a microscope. Only naked nuclei that stained blue were calculated.
2.5. Ultrastructure of Filer Membrane
At the end of experiment, the membrane of the leukocyte filter was taken for transmission electron microscopy as reported previously [3, 19]. Samples were fixed in 3% glutaraldehyde at 4°C overnight and then fixed with 1% osmium tetroxide, dehydrated with acetone, and embedded in Epon812. The ultrathin sections were double stained with uranyl acetate and lead citrate and examined under a transmission electron microscope (H-600IV, Hitachi, Osaka, Japan).
Data were analyzed by SPSS 16.0 (SPSS, Inc, Chicago, Ill). Quantitative data were expressed by the mean ± SD, and one-way ANOVA with Student-Newman-Keuls test was used to compare differences among the 3 groups. Segmental data were expressed as a percentage, and the differences between the 3 groups were compared using the chi-square test. A value of was considered statistically significant.
3.1. Long-Term Filtration Removed and Activated Leukocytes
Leukocyte counts were similar among the 3 groups before ECC and decreased by 90% after 5 min of filtration in groups L and S (Figure 1(a)). Then, it continued to decrease throughout 60 min of ECC in Group L.
Mean fluorescent intensities (MFIs) of CD11/CD18 on leukocyte increased significantly in both groups L and S compared with that in Group C at 5 min ECC (Figure 1(a′), ). Thereafter, MFIs of CD11/CD18 in the leukocyte increased sharply in group L, while it increased gradually in groups C and S. Neutrophils and lymphocytes, and expression of CD11/CD18 had a similar pattern (Figures 1(b), 1(c), 1(b′), and 1(c′)).
NE is released most from the activated leukocyte, and induces an inflammatory response in blood and tissues. To confirm leukocyte activation, plasma NE was determined. NE level in Group L increased significantly at 30 min of filtration, and continued to increase to 60 min (Figure 2(c)). It was significantly higher in Group L than groups S and C.
3.2. Long-Term Filtration Accelerated Erythrocyte Injury
To determine whether erythrocyte destruction is associated with activated neutrophils during ECC, fHb levels in plasma were measured. Hemoglobin (a) and fHb (b) levels were similar among the 3 groups before ECC (Figure 2). The fHb level increased during ECC, and was significantly higher in Group L than in the other 2 groups at 30 and 60 min (). Furthermore, the fHb level was lower in Group S than in Group C.
3.3. Leukocytes Were Ruptured by Filtration
Wright’s stain and transmission electron microscopy analyses showed significant leukocyte rupture in Group L (Figure 3), indicated by cellular membrane rupture and cytoplasmic leakage ((a), yellow arrow). Accordingly, the percentage of naked nuclei in blood was highest in Group L.
Our study is the first in vitro approach that focused on filtration induced inflammation. Using the extracorporeal circulation (ECC) model in vitro, we clearly showed that effectiveness of leukocyte filtration depends on exposure time during ECC. Short-term use of a leukocyte filter reduced circulating leukocytes; with continued usage, leukocytes that adhered to the filter membrane disrupted, leading to leakage of protease, inflammatory reaction, and tissue destruction. Our results may explain why leukocyte depletion could not improve the outcomes in some clinical studies [12–14].
Studying the effect of filtration on inflammation is difficult in vivo, because inflammatory products are processed by the immune system. For example, naked nuclei in the circulation would be engulfed. Therefore, the in vitro model may be a necessary approach. In this in vitro model, circulating leukocytes were significantly reduced with a 5 min short-term filtration (about 5–7 circles). The leukocyte filter was then bypassed, and leukocytes adhered to the membrane were no longer exposed to the circulation. Our results support a short-term usage of the filter because the concentration of fHb was lower in Group S than in Group C. This is in agreement with several clinic trials. Morioka et al.  and Chiba et al.  found leukocyte depletion before ECC significantly attenuated both myocardial and lung injuries induced by cardiopulmonary bypass. In patients with systemic inflammatory response syndrome, a short-term leukocyte depletion significantly improved organ function and outcomes . In patients with chronic obstructive pulmonary diseases, leukocyte filtration at early reperfusion (30 min) improved oxygenation and shortened intubation and ICU and hospital times .
Efficiency of a filter is determined by membrane area and filtration time. The filtration would reach its maximal capacity by prolonging filtering time. Then, the number of circulating leukocytes would not change with continued use of the filter; however, damaging effects on leukocytes develop, which compromises the beneficial effect of the filter. An optimal length of time for filter use should be available.
Previous studies have observed that leukocyte filtration did not inhibit, but activated leukocytes [14–17]. This is consistent with our results that CD11/CD18 expression on leukocytes was significantly upregulated with long-term filtration, which induces leukocyte sequestration in the tissues. Furthermore, leukocytes adhered to the membrane were elongated and ruptured under the transmission electron microscope after long-term filtration. This result was confirmed by a high level of circulating naked nucleus count and neutrophil elastase. Taken together, our results indicate that long-term filtration during ECC induces leukocyte rupture.
Activated leukocytes induce tissue injury via obstruction of microcirculation and release of proteases, such as neutrophil elastase. In the present study, neutrophil elastase and free hemoglobin increased in Group L significantly, suggesting that long-term usage of leukocyte filtration exerts deleterious side effects. This statement can be verified by the fact that aprotinin, a serine proteases inhibitor, significantly improves lung function and reduces the incidence of atrial fibrillation in patients treated with a leukocyte filter .
Although our results showed that short-term filtration may effectively inhibit inflammatory reactions and reduce erythrocyte destruction, whether it would improve patient outcomes requires further in vivo studies.
In conclusion, our results clearly show that long-term filtration can induce leukocyte destruction and evoke inflammatory reactions and should be avoided.
Conflict of Interests
The authors hereby declare no conflict of interests.
Jiali Tang, Kaiyu Tao, and Jing Zhou contributed equally to this paper.
This work was supported by the National Natural Science Foundation of China Grants 81171651 and 81270324. The authors also thank Jerry Yu, M.D., Ph.D., Department of Pulmonary Medicine, University of Louisville, Louisville, KY, for his advice and revision of the paper.
- M. Tönz, T. Mihaljevic, L. K. Von Segesser, J. Fehr, E. R. Schmid, and M. I. Turina, “Acute lung injury during cardiopulmonary bypass are the neutrophils responsible?” Chest, vol. 108, no. 6, pp. 1551–1556, 1995.
- D. Cameron, “Initiation of white cell activation during cardiopulmonary bypass: cytokines and receptors,” Journal of Cardiovascular Pharmacology, vol. 27, no. 1, supplement, pp. S1–S5, 1996.
- J. Zhou, X.-D. Wu, K. Lin et al., “Blood hibernation: a novel strategy to inhibit systemic inflammation and coagulation induced by cardiopulmonary bypass,” Chinese Medical Journal, vol. 123, no. 13, pp. 1741–1747, 2010.
- L. Du, J. Zhou, J. Zhang et al., “Actin filament re-organization is a key step in lung inflammation induced by systemic inflammatory response syndrome,” American Journal of Respiratory Cell and Molecular Biology, vol. 47, pp. 597–603, 2012.
- L. Du, J. Zhou, J. Tang et al., “Aprotinin combined with nitric oxide and prostaglandin E1 protects the canine kidney from cardiopulmonary bypass-induced injury,” European Journal of Cardio-Thoracic Surgery, vol. 38, no. 1, pp. 98–103, 2010.
- S. T. Baksaas, H. I. Flom-Halvorsen, E. Øvrum et al., “Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery,” Perfusion, vol. 14, no. 2, pp. 107–117, 1999.
- Y. J. Gu, A. J. De Vries, P. W. Boonstra, and W. Van Oeveren, “Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery,” Journal of Thoracic and Cardiovascular Surgery, vol. 112, no. 2, pp. 494–500, 1996.
- C. G. de Amorim, L. M. Malbouisson, F. C. da Silva Jr. et al., “Leukocyte depletion during CPB: effects on inflammation and lung function,” Inflammation. In press.
- S. Gunaydin, T. Modine, T. Sari, Y. Zorlutuna, and T. Gourlay, “Clinical efficacy of two-phase leukocyte filtration in high-risk patients undergoing coronary revascularization with cardiopulmonary bypass,” Journal of Extra-Corporeal Technology, vol. 41, no. 3, pp. 149–156, 2009.
- A. S. Rubino, G. F. Serraino, R. Marsico et al., “Leukocyte filtration improves pulmonary function and reduces the need for postoperative non-invasive ventilation,” International Journal of Artificial Organs, vol. 35, pp. 679–688, 2012.
- S. T. Baksaas, V. Videm, T. E. Mollnes et al., “Leucocyte filtration during cardiopulmonary bypass hardly changed leucocyte counts and did not influence myeloperoxidase, complement, cytokines or platelets,” Perfusion, vol. 13, no. 6, pp. 429–436, 1998.
- A. G. Loberg, J. Stallard, J. Dunning, and J. Dark, “Can leucocyte depletion reduce reperfusion injury following cardiopulmonary bypass?” Interactive Cardiovascular and Thoracic Surgery, vol. 12, no. 2, pp. 232–237, 2011.
- A. S. Rubino, G. F. Serraino, G. Mariscalco, R. Marsico, A. Sala, and A. Renzulli, “Leukocyte depletion during extracorporeal circulation allows better organ protection but does not change hospital outcomes,” Annals of Thoracic Surgery, vol. 91, no. 2, pp. 534–540, 2011.
- M. Scholz, A. Simon, G. Matheis et al., “Leukocyte filtration fails to limit functional neutrophil activity during cardiac surgery,” Inflammation Research, vol. 51, no. 7, pp. 363–368, 2002.
- M. Ilmakunnas, E. J. Pesonen, J. Ahonen, J. Rämö, S. Siitonen, and H. Repo, “Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass,” Journal of Thoracic and Cardiovascular Surgery, vol. 129, no. 4, pp. 851–859, 2005.
- V. A. Ferraris, J. R. Brown, G. J. Despotis et al., “2011 update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines,” Annals of Thoracic Surgery, vol. 91, no. 3, pp. 944–982, 2011.
- S. Schneider, H. Gunasinghe, J. Sistino, M. Blackwell, and F. Spinale, “Effects of leukocyte depletion filters on matrix metalloproteinase activation in an extracorporeal circulation circuit,” Journal of Extra-Corporeal Technology, vol. 35, no. 2, pp. 139–142, 2003.
- K. Tao, Q. An, K. Lin et al., “Which is better to preserve pulmonary function: short-term or prolonged leukocyte depletion during cardiopulmonary bypass?” Journal of Thoracic and Cardiovascular Surgery, vol. 138, no. 6, pp. 1385–1391, 2009.
- L. Du, L. Gong, L. Li et al., “The feasibility of karyocyte scavenger for intraoperative blood salvage during oncosurgery,” Chinese Journal of Blood Transfusion, vol. 24, pp. 644–649, 2011.
- G. P. Lewis, “Method using ortho-tolidine for the quantitative determination of haemoglobin in serum and urine,” Journal of Clinical Pathology, vol. 18, pp. 235–239, 1965.
- K. Crozat, C. Eidenschenk, B. N. Jaeger et al., “Impact of β2 integrin deficiency on mouse natural killer cell development and function,” Blood, vol. 117, no. 10, pp. 2874–2882, 2011.
- K. Morioka, R. Muraoka, Y. Chiba et al., “Leukocyte and platelet depletion with a blood cell separator: effects on lung injury after cardiac surgery with cardiopulmonary bypass,” Journal of Thoracic and Cardiovascular Surgery, vol. 111, no. 1, pp. 45–54, 1996.
- Y. Chiba, K. Morioka, R. Muraoka et al., “Effects of depletion of leukocytes and platelets on cardiac dysfunction after cardiopulmonary bypass,” Annals of Thoracic Surgery, vol. 65, no. 1, pp. 107–114, 1998.
- D. F. Treacher, M. Sabbato, K. A. Brown, and V. Gant, “The effects of leucodepletion in patients who develop the systemic inflammatory response syndrome following cardiopulmonary bypass,” Perfusion, vol. 16, supplement, pp. 67–73, 2001.
- T. E. Karaiskos, G. M. Palatianos, C. D. Triantafillou et al., “Clinical effectiveness of leukocyte filtration during cardiopulmonary bypass in patients with chronic obstructive pulmonary disease,” Annals of Thoracic Surgery, vol. 78, no. 4, pp. 1339–1344, 2004.
- A. H. Olivencia-Yurvati, N. Wallace, S. Ford, and R. T. Mallet, “Leukocyte filtration and aprotinin: synergistic anti-inflammatory protection,” Perfusion, vol. 19, no. 1, pp. S13–S19, 2004.
Copyright © 2013 Jiali Tang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.